Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 307-310

  Stoiber, Heribert ^a   Pintér, Claudia ^b   Siccardi, Antonio G ^c   Clivio, Alberto ^b   Dierich, Manfred P ^a,d  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY OF MILAN   (Italy)

^c Dipto di Biol e Tecn San Raffaele   (Italy)

^d Institut für Hygiene und Sozialmedizin   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; PRIORITY JOURNAL; SERUM; VIRUS NEUTRALIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD55; BLOOD; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS;

EID: 0030064149     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.307     Document Type: Article

References (25)

1. Ebenbichler, C., N. Thielens, G Arlaud, and M.P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174:944-952.
2. Banapour, B., J. Sernatinger, and J. Levy. 1986. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology. 152:286-271.
3. Spear, G.T., B.L. Sullivan, D.M. Takefman, A.L. Landay, and T.F. Lint. 1991. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis. Immunology. 73:377-382.
4. Spear, G.T , B.L. Sullivan, A.L. Landay, and T.F. Lint. 1990. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J. Virol. 64:5869-5873.
5. Stoiber, H., N. Thielens, C. Ebenbichler, G. Arlaud, and M.P. Dierich. 1994. The envelope glycoprotein of HIV-1 gp120 and the human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenetic homology. Eur. J. Immunol. 24:294-300.
6. Ezekowitz, A.B., M. Kuhlman, J.E. Groopman, and R.A. Byrn. 1989. A human serum mannose-binding protein inhibits in vitro infection by the immunodeficiency virus. J. Exp Med. 169:185-196.
7. Marschang, P., J. Sodroski, R. Würzner, and M.P. Dierich. 1995. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25:285-290.
8. Saifuddin, M., C.J. Parker, M.E. Peeples, M.K., Gorny, S. Zolla-Pazner, M. Ghassemi, I.A. Rooney, J.P. Atkinson, and G.T. Spear. 1995. Role of virion-associated glycosylphosphatidylmositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. Exp. Med. 182:501-509.
9. Pintér, C., A.G. Siccardi, R. Longhi, and A. Clivio. 1995. Direct interaction of complement factor H with the C1 domain of HIV-1 gp120. AIDS Res. Hum Retroviruses. 5:577-588.
10. Stoiber, H., C. Ebenbichler, R. Schneider, J. Janatova, and M.P. Dierich. 1995. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS (Phila). 9:19-26.
11. Pintér, C., A.G. Siccardi, L. Lopalco, R., Longhi, and A. Clivio. 1995. HIV gp-41 and complement factor H interact with each other and share functional as well as antigenic homology. AIDS Res. Hum. Retroviruses. 11:971-980.
12. Stoiber, H., R. Schneider, J. Janatova, and M.P. Dierich. 1995. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology. 193:98-113.
13. Weller, J.M., M.R. Daha, K.F. Austen, and D.T. Fearon. 1976. Control of amplification convertase of complement by the plasma protein β1H. Proc. Natl Acad. Sci. USA. 73:3268-3272.
14. Pangburn, M.K., R.D. Schreiber, and H.J. Müller-Eberhard. 1981. Formation of the initial C3 covertase of the alternative complement pathway. J. Exp. Med. 154:856-867.
15. Law, S.K.A., and K.B.M. Ried, editors. 1988. Complement. IRL Press, Oxford, UK 1-72.
16. Misiano, G., CJ. Soames, M. Fontaine, P. Accardo, R.B. Sim, and M. Brai. 1993. Expression of H-related gene products in a factor H deficient family. Mol. Immunol. 30:33.
17. Muster, T., R. Guinea, A. Trkola, M. Purtscher, A. Klima, F. Steindl, P. Palese, and H. Katinger. 1994, Cross-neutralization activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS J. Virol. 68:4031-4034.
18. Folks, T.M., D. Powell, M. Lightfoot, S. Koenig, A. Fauci, S. Benn, A. Rabson, D. Daugherty, H.E. Gendelman, M.D. Hoggan, et al. 1986. Biological and biochemical characterization of a cloned Leu3 cell surviving infection with the acquired immunodeficiency syndrome retrovirus. J. Exp. Med. 164:280-290.
19. Horstmann, R.D., H.J. Sieverts, J Knobloch, and V.A Fischetti. 1988. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA. 85:1657-1661.
20. Delibrias, C.C., M.D. Kazatchkine, and E. Fischer. 1993. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand. J. Immunol. 38:183-189.
21. Reisinger, E., W. Vogetseder, D. Berzow, D. Kötler, G. Bitterlich, H.A. Lehr, H. Wachter, and M.P. Dierich. 1989. Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS (Phila.). 4:961-965
22. Tremblay, M S., S. Meloche, R.P. Sekaly, and M.A.J. Wainberg. 1990. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus carrying B cells. J. Exp. Med. 171:1791-1796.
23. Robinson, W.E., D.C. Montefiori, and W.M. Mitchell. 1988. Antibody dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. i:790-794.
24. Sölder, B.M., E.C. Reisinger, D. Köfler, G. Bitterlich, H. Wachter, and M.P. Dierich. 1989. Complement receptors: another port of entry for HIV. Lancer. ii:271-272.
25. Dierich, M.P., C. Ebenbichler, P. Marschang, G. Füst, N. Thielens, and G. Arlaud, 1993. HIV and human complement: mechanisms of interaction and biological implications. Immunol. Today. 14:435-440.